Milestone Pharmaceuticals Inc
MIST
$1.13+8.65%
Delayed · as of Aug 25, 2026, 1:15 PM ET
Mkt cap
$160.60M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$559,000
EPS (H1 2026)
$-0.41
Gross Margin (qtr ended 2026-06-30)
94.28%
Profit Margin (qtr ended 2026-06-30)
-5118.78%
Beta
1.04
Div yield
N/A
Sector
Healthcare
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
Latest reported MIST revenue for 2026-06-30 was $559.0K. Net income was -$28.6M. MIST currently screens at market cap $160.6M.
Use this MIST research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MIST income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company in the Healthcare sector.
Latest cached Milestone Pharmaceuticals Inc (MIST) revenue for Jun 30, 2026 was $559.0K. Net income was -$28.6M. Statements: https://lician.com/financials/mist
Milestone Pharmaceuticals Inc (MIST) market capitalization is $160.6M on the latest cached snapshot.
Milestone Pharmaceuticals Inc (MIST) cached previous close $1.04; day range $1.05 – $1.15; volume 886,949. Session quote: https://lician.com/quote/mist
Milestone Pharmaceuticals Inc (MIST) latest cached earnings event is "MIST earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MIST filing is 8-K · Sep 3, 2026. Filings: https://lician.com/sec/mist